USD 3.99
(2.84%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 73.79 Million USD | 7.42% |
2022 | 68.7 Million USD | -18.99% |
2021 | 84.8 Million USD | 39.16% |
2020 | 60.93 Million USD | 56.76% |
2019 | 38.87 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 65.61 Million USD | -11.09% |
2024 Q2 | 66.72 Million USD | 1.69% |
2023 Q2 | 84.58 Million USD | -2.11% |
2023 Q3 | 74.3 Million USD | -12.15% |
2023 Q1 | 86.4 Million USD | 25.76% |
2023 FY | 73.79 Million USD | 7.42% |
2023 Q4 | 73.79 Million USD | -0.67% |
2022 Q3 | 76.26 Million USD | -5.15% |
2022 Q4 | 68.7 Million USD | -9.91% |
2022 FY | 68.7 Million USD | -18.99% |
2022 Q1 | 94.29 Million USD | 11.2% |
2022 Q2 | 80.4 Million USD | -14.74% |
2021 Q3 | 83.3 Million USD | 2.89% |
2021 FY | 84.8 Million USD | 39.16% |
2021 Q4 | 84.8 Million USD | 1.8% |
2021 Q2 | 80.96 Million USD | 170.15% |
2021 Q1 | 29.96 Million USD | -50.82% |
2020 FY | 60.93 Million USD | 56.76% |
2020 Q2 | 86 Thousand USD | 0.0% |
2020 Q3 | 8.1 Million USD | 9320.57% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 60.93 Million USD | 652.18% |
2019 FY | 38.87 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Abbott Laboratories | 34.38 Billion USD | 99.785% |
Allurion Technologies Inc. | 142.19 Million USD | 48.102% |
Artivion, Inc. | 510.61 Million USD | 85.547% |
Avanos Medical, Inc. | 456.1 Million USD | 83.82% |
Butterfly Network, Inc. | 84.22 Million USD | 12.375% |
Butterfly Network, Inc. | 84.22 Million USD | 12.375% |
Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 97.926% |
Boston Scientific Corporation | 15.6 Billion USD | 99.527% |
CONMED Corporation | 1.46 Billion USD | 94.965% |
Edwards Lifesciences Corporation | 2.64 Billion USD | 97.209% |
Paragon 28, Inc. | 162.95 Million USD | 54.713% |
Glaukos Corporation | 478.64 Million USD | 84.582% |
Globus Medical, Inc. | 1.08 Billion USD | 93.218% |
Inspire Medical Systems, Inc. | 104.29 Million USD | 29.241% |
Integer Holdings Corporation | 1.41 Billion USD | 94.778% |
Medtronic plc | 39.56 Billion USD | 99.813% |
Myomo, Inc. | 5.59 Million USD | -1219.673% |
Nevro Corp. | 330.31 Million USD | 77.658% |
Penumbra, Inc. | 377.36 Million USD | 80.443% |
Vicarious Surgical Inc. | 21.89 Million USD | -237.059% |
Smith & Nephew plc | 4.77 Billion USD | 98.453% |
STERIS plc | 4.74 Billion USD | 98.446% |
Stryker Corporation | 21.31 Billion USD | 99.654% |
Vapotherm, Inc. | 132.95 Million USD | 44.492% |
Zimmer Biomet Holdings, Inc. | 9 Billion USD | 99.181% |